1. Boots, J. W. P. (2006). Protein hydrolysates enriched in peptides inhibiting DPP-IV and their use. In Campina Nederland Holding B.V. World Organisation (Ed.), Vol. US 8273710. Nederland. PCT Patent Application WO/2006/068480.
2. Chen, Y. H., Yang, Y. H., Liu, Y. H., Chang, C. T., Feng, H. H., & Chen, C. C. (2008). Peptides used as angiotensin converting enzyme inhibitor and preparation process thereof. Patent US 6767990 B1.
3. Development of a seaweed derived platelet activating factor acetylhydrolase (PAF-AH) inhibitory hydrolysate, synthesis of inhibitory peptides and assessment of their toxicity using the Zebrafish larvae assay;Fitzgerald;Peptides,2013
4. Isolation and characterization of bioactive pro-peptides with in vitro renin inhibitory activities from the macroalga Palmaria palmata;Fitzgerald;Journal of Agricultural and Food Chemistry,2012
5. Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents;Green;Current Pharmaceutical Design,2004